- RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications
Dan Ke et al, 2023, Frontiers in Immunology CrossRef - Gut Metabolite Trimethylamine-N-Oxide in Atherosclerosis: From Mechanism to Therapy
BingYu Wang et al, 2021, Frontiers in Cardiovascular Medicine CrossRef